Krensavage Asset Management as of June 30, 2021
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 13 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | 15.6 | $46M | 82k | 558.54 | |
| Alkermes (ALKS) | 14.1 | $41M | 1.7M | 24.52 | |
| Enanta Pharmaceuticals (ENTA) | 14.0 | $41M | 940k | 44.01 | |
| United Therapeutics Corporation (UTHR) | 13.4 | $39M | 220k | 179.41 | |
| Taro Pharmaceutical Industries (TARO) | 13.3 | $39M | 544k | 71.96 | |
| Biogen Idec (BIIB) | 11.5 | $34M | 98k | 346.27 | |
| McKesson Corporation (MCK) | 10.8 | $32M | 166k | 191.24 | |
| Rti Biologics | 3.0 | $8.9M | 6.4M | 1.39 | |
| Invacare Corporation | 2.5 | $7.3M | 902k | 8.07 | |
| Eagle Pharmaceuticals (EGRX) | 1.0 | $3.0M | 71k | 42.79 | |
| Travere Therapeutics (TVTX) | 0.7 | $2.0M | 140k | 14.59 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $282k | 11k | 25.90 | |
| Nextcure (NXTC) | 0.1 | $252k | 31k | 8.04 |
